Targeting Rare Biomarkers: A New Frontier in Non-Small Cell Lung Cancer Treatment
  Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths worldwide. Recent breakthroughs in understanding the molecular underpinnings of NSCLC have highlighted the importance of rare biomarkers in optimizing treatment options. The discovery of these biomarkers has paved the way for targeted therapies that have drastically altered the treatment landscape. As we...
0 Komen 0 Perkongsian 92 Views 0 review
adstera